JPMORGAN CHASE & CO - CLEMENTIA PHARMACEUTICALS IN ownership

CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 27 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$41,702,000
+139.8%
1,597,795
+8.0%
0.01%
+125.0%
Q4 2018$17,391,000
+50.4%
1,478,880
+42.6%
0.00%
+100.0%
Q3 2018$11,563,000
-0.3%
1,037,047
+17.6%
0.00%0.0%
Q2 2018$11,603,000
+2.8%
881,711
+18.4%
0.00%0.0%
Q1 2018$11,285,000
-15.8%
744,869
+5.5%
0.00%
-33.3%
Q4 2017$13,406,000
+22.6%
706,297
+8.0%
0.00%
+50.0%
Q3 2017$10,937,000653,7220.00%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$197,871,0002.50%
NEA Management Company, LLC 2,141,697$40,649,0001.68%
RA Capital Management 585,403$11,111,0000.93%
DRIEHAUS CAPITAL MANAGEMENT LLC 862,279$16,366,0000.62%
DAFNA Capital Management LLC 60,000$1,139,0000.61%
EcoR1 Capital, LLC 194,166$3,685,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 163,000$3,094,0000.36%
Rock Springs Capital Management LP 345,000$6,548,0000.30%
Birchview Capital, LP 22,000$418,0000.24%
SECTORAL ASSET MANAGEMENT INC 75,313$1,429,0000.18%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders